0
ARTICLE |

Serologic Tests for Antibody to Borrelia burgdorferi Another Pandora's Box for Medicine?

CRAIG W. HEDBERG, MS; MICHAEL T. OSTERHOLM, PHD, MPH
Arch Intern Med. 1990;150(4):732-733. doi:10.1001/archinte.1990.00390160010002.
Text Size: A A A
Published online

Much has been written about serologic tests for antibody to Borrelia burgdorferi and their use in the diagnosis of Lyme disease since it first became available in 1983.1Borrelia burgdorferi antibody serologic tests have offered much promise for improving the diagnosis of Lyme disease and for increasing our knowledge of its epidemiology. However, like "Pandora's box," they have presented us with many unforeseen difficulties. Numerous researchers, reviewers, and editorial writers have wrestled with the merits of alternative test methods, 2-5 low test See also p 761. sensitivity during the early stages of Lyme disease, 6 cross-reactivity with other spirochetal organisms, 7 interlaboratory variability with tests that are not standardized, 8 and the lack of clinical significance of "positive" serologic test results in patients who do not have Lyme disease.9,10 As the clinical use of B burgdorferi antibody serologic tests has (apparently) moved forward, Luger and Krause11 entered

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 23

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs